Lyell Immunopharma LYEL
NASDAQ LYEL
$9.26 -0.15 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lyell Immunopharma (LYEL) Asset Writedowns and Impairment (2021 - 2025)

Updated

Lyell Immunopharma (LYEL) posted Asset Writedowns and Impairment of $1.44 million for FY2025, down 97.2% from $51.3 million in FY2024.

Analysis

Lyell Immunopharma (LYEL) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends

  • Annual Asset Writedowns and Impairment shows a four-year compound annual growth rate of -55.4% (FY2021 to FY2025).
  • Business Quant data shows LYEL's Asset Writedowns and Impairment at $51.3 million in FY2024 and $36.4 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Lyell Immunopharma 216.66 Mn 216.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.44 Mn
Dec 31, 2024 51.30 Mn
Dec 31, 2022 -5.00 Mn
Sep 30, 2022 5.00 Mn
Dec 31, 2021 36.40 Mn
API Access

Lyell Immunopharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=LYEL&period=max&api_key=YOUR_API_KEY